ArticleJuntendo medical journal2025
History of Disseminated Intravascular Coagulation (DIC) Research and My Personal Research History.
Article in Juntendo medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [Risk factors and prognosis of disseminated intravascular coagulation in patients with non-M(3) acute myeloid leukemia].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026Article
- Recognizing Coagulation Disorders in Sepsis in the Emergency Room: A Narrative Review.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disseminated intravascular coagulation (DIC) is like a cloud. We really can see it, but we never feel or touch it. This means that we can diagnose it, but we still do not know how that happens and how to manage it. DIC was first recognized as an uncontrollable bleeding disorder complicated by critical diseases. Curiously, despite such bleeding tendency, pathological examination revealed systemic micro-clot formation in multiple organs. Soon after, these specific findings were revealed as the result of excess coagulation followed by consumptive coagulopathy. Numerous factors, such as imbalanced coagulation/fibrinolysis, endothelial damage, platelet activation, and intravascular inflammation, are involved in the pathogenesis. However, the whole story has not been clarified yet, and DIC is also recognized as "Disseminated Intracerebral Confusion." In nearly 40 years, several diagnostic criteria were proposed but never integrated. As for the sepsis-associated DIC, the International Society on Thrombosis and Haemostasis recommended a two-step approach by Sepsis-Induced Coagulopathy (SIC) followed by overt DIC criteria. In this approach, the early (compensated)-phase is diagnosed by SIC, and the late (decompensated)-phase is diagnosed by overt DIC criteria. Regarding treatment, we are very sorry, but only the treatment for underlying conditions is recommended. However, aggressive anticoagulant therapies for early-phase DIC have been explored in Japan. We expect the effects of anticoagulant therapy to be proven in the near future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.